Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "skin tissue regeneration pathway" refers to the complex series of molecular and cellular events triggered by skin injury, featuring the coordinated action of immune cells, keratinocytes, fibroblasts, endothelial cells, hair follicle stem cells, and other appendage-related cells[1][3][4]. This process involves overlapping stages—hemostasis, inflammation, proliferation, reepithelialization, tissue remodeling, and eventual maturation or scarring[1][4]. Key biological activities include migration, proliferation, differentiation, and coordinated secretion of cytokines, chemokines, growth factors, and extracellular matrix proteins. Intracellular and paracrine signaling mechanisms, such as Wnt, BMP, chemokine, and mechanotransduction pathways (e.g., via focal adhesion kinase), critically impact outcomes such as scarless healing versus fibrosis[2][5]. As a general biological process, it is foundational to wound healing and tissue regeneration medicine, but it does not denote a single molecular drug target[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin tissue regeneration pathway.